S. Eva Singletary

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

W. Fraser Symmans, Florentia Peintinger, Christos Hatzis et al. · Journal of Clinical Oncology · 2007 · 1.6K citations · Full text

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

S. Eva Singletary, Craig Allred, Pandora Ashley et al. · Journal of Clinical Oncology · 2002 · 1.2K citations

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology

Mary Richardson, Tina Sanders, J. Lynn Palmer et al. · Journal of Clinical Oncology · 2000 · 1K citations